Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Donor-derived cell-free DNA is associated with acute rejection and decreased oxygenation in primary graft dysfunction after living donor-lobar lung transplantation

12 Oct 2018

Abstract excerpt

Donor-derived cell-free DNA (dd-cf-DNA) has been shown to be an informative biomarker of rejection after lung transplantation (LT) from deceased donors. However, in living-donor lobar LT, because small grafts from blood relatives are implanted with short ischemic times, the detection of dd-cf-DNA might be challenging. Our study was aimed at examining the role of dd-cf-DNA measurement in the diagnosis of primary...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Renal Transplantation Outcomes and Treatments
Share to Transplantation: Methods and Outcomes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30337621
DOI: 10.1038/s41598-018-33848-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Donor-derived cell-free DNA is associated with acute rejection and decreased oxygenation in primary graft dysfunction after living donor-lobar lung transplantationPMID 30337621Read ↗

Cell-free DNA in human ex vivo lung perfusate as a potential biomarker to predict the risk of primary graft dysfunction in lung transplantationSemantic proximity Read ↗

Donor-derived cell-free DNA is a valuable monitoring tool after single lung transplantation: Multicenter analysisSemantic proximity Read ↗

Why Cell-Free DNA Can Be a “Game Changer” for Lung Allograft Monitoring for Rejection and InfectionSemantic proximity Read ↗

Nuances in the interpretation and utility of donor-derived cell-free DNA in lung transplantation following allogeneic hematopoietic stem cell transplantation - Case report.Semantic proximity Read ↗

The role of donor-derived cell-free DNA in the detection of renal allograft injurySemantic proximity Read ↗

Graft-derived Cell-free DNA as a Noninvasive Biomarker of Cardiac Allograft Rejection: A Cohort Study on Clinical Validity and Confounding FactorsSemantic proximity Read ↗

Cell-Free DNA: An Upcoming Biomarker in TransplantationSemantic proximity Read ↗

Rapid detection of donor cell free DNA in lung transplant recipients with rejections using donor-recipient HLA mismatchSemantic proximity Read ↗

Donor-Derived Cell-Free DNA Is a Novel Universal Biomarker for Allograft Rejection in Solid Organ TransplantationSemantic proximity Read ↗

Donor-derived cell-free DNA-based liquid biopsies to determine future kidney transplant rejectionSemantic proximity Read ↗

Noninvasive monitoring of infection and rejection after lung transplantation.Semantic proximity Read ↗

Cell-free DNA in ex-vivo lung perfusate is associated with low-quality lungs and lung transplant outcomeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.